Oncternal Therapeutics In...

NASDAQ: ONCT · Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM

Oncternal Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.7M 37.14M 90.77M
Short-Term Investments
27.56M 26.58M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
412K 1.27M 657K
Receivables
632K 178K 944K
Inventory
n/a 103K -944K
Other Current Assets
606K n/a 359K
Total Current Assets
36.06M 67.29M 92.85M
Property-Plant & Equipment
258K 87K 75K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
670K 1.36M 732K
Total Assets
36.73M 68.65M 93.58M
Account Payables
1.15M 2.92M 1.96M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
1.58M n/a n/a
Total Current Liabilities
5.2M 7.68M 5.46M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
1.33M n/a n/a
Total Long-Term Liabilities
1.48M 3M n/a
Total Liabilities
6.68M 7.68M 5.46M
Total Debt
318K 87K 75K
Common Stock
3K 57K 49K
Retained Earnings
-197.78M -158.3M -114.13M
Comprehensive Income
3K 9K n/a
Shareholders Equity
30.05M -158.3M -114.13M
Total Investments
27.56M 26.58M n/a